INFECTIVITY OF HEPATIC ALLOGRAFTS WITH ANTIBODIES TO HEPATITIS B VIRUS
- 1 December 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 64 (11) , 1582-1584
- https://doi.org/10.1097/00007890-199712150-00013
Abstract
Since suitable recipients for hepatic allografts from donors with antibodies to hepatitis B virus (HBV) have not been determined, a review of our 7-year experience with donors positive for hepatitis B surface antibody (anti-HBs), hepatitis B core antibody (anti-HBc), or both was undertaken. Recipients of hepatic allografts from donors with antibodies to HBV were identified by a retrospective review of procurement records and screened for HBV infection. From January 1, 1990, to January 1, 1997, 2578 liver transplants were performed and 140 (5.4%) recipients received an allograft from a donor with antibodies to HBV. Twenty-five of 48 recipients of a hepatic allograft from a donor positive only for anti-HBs were screened and none developed HBV infection. Twenty-five of 41 naive recipients of a hepatic allograft from an anti-HBc positive donor were screened and 18/25 (72%) developed HBV infection. Four of these 18 naive recipients with HBV infection received an allograft from a donor positive for both anti-HBc and anti-HBs. Seven of 13 anti-HBs-positive recipients of an allograft from an anti-HBc-positive donor were screened and none developed HBV infection. Fifteen of 16 recipients positive only for anti-HBc who received a hepatic allograft from an anti-HBc-positive donor were screened and 2/15 (13%) developed HBV infection. Hepatic allografts from donors positive only for anti-HBs do not transmit HBV infection. Hepatic allografts from anti-HBc-positive donors frequently transmit HBV infection to naive recipients regardless of the donor anti-HBs status, and antiviral prophylaxis may be indicated. Anti-HBs-positive recipients appear resistant to HBV infection after orthotopic liver transplantation with an allograft from an anti-HBc-positive donor. Recipients positive only for anti-HBc infrequently develop HBV infection when transplanted with an allograft from an anti-HBc-positive donor; however, HBV prophylaxis may be justified.Keywords
This publication has 8 references indexed in Scilit:
- The clinical course of transplantation-associated de novo hepatitis B infection in the liver transplant recipientLiver Transplantation and Surgery, 1997
- Lamivudine results in a complete and sustained suppression of hepatitis B virus replication in patients requiring orthotopic liver transplantation for cirrhosis secondary to hepatitis BHepatology, 1995
- Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virusJournal of Hepatology, 1995
- The Risk Of Transmission Of Hepatitis B From Hbsag(-), Hbcab(+), Hbigm(-) Organ DonorsTransplantation, 1995
- "Occult" hepatitis B virus as source of infection in liver transplant recipientsThe Lancet, 1994
- Liver Transplantation in European Patients with the Hepatitis B Surface AntigenNew England Journal of Medicine, 1993
- Response to hepatitis B vaccination by liver transplant candidatesDigestive Diseases and Sciences, 1992
- Protection against hepatitis B virus infection by immunization with hepatitis B core antigenGastroenterology, 1985